Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Role in GLOW TB-4 supports the movement of repair cells through damaged tissue and the organization of the rebuilding process
Combination Administration When running both compounds simultaneously, the injection schedules remain separate
Genetic and nongenetic factors associated with protein abundance of Flavin-containing Monooxygenase 3 in human liver
Taking it daily, including rest days, may help maintain consistent levels and support overall metabolic processes
GHRH Peptides Side-by-Side Feature Receptor Target Tesamorelin GHRH receptor Sermorelin GHRH receptor CJC-1295 (DAC) GHRH receptor Feature Peptide Length Tesamorelin 44 amino acids (modified) Sermorelin 29 amino acids CJC-1295 (DAC) 29 amino acids + DAC Feature Half-Life Tesamorelin 26-38 minutes Sermorelin 11-12 minutes CJC-1295 (DAC) ~6-8 days Feature Dosing Frequency Tesamorelin Once daily Sermorelin Once nightly CJC-1295 (DAC) 1-2x weekly Feature FDA Status Tesamorelin Approved (2010
